Skip to main content

HighRes® and Waters Collaborate to Advance Drug Discovery through Robotic Automation

Beverly, MA (June 23, 2026) – HighRes® today announced a strategic collaboration to enable robotic capabilities on Waters Biosciences, formerly BD Biosciences, flow cytometers to automate key experimental steps and streamline research workflows, from basic research to drug discovery.

The companies are integrating the BD FACSLyric™ Flow Cytometer1 with the HighRes Nucleus Automation and Cellario Software Platforms, enabling scientists to utilize robotic arm capabilities to run reliable, complex, multi-step experiments unattended with continuous operation of up to three times more experimental runs per day. The integration enables higher-throughput studies, improves reproducibility, and allows for greater operational efficiency.

 

Labs interested in deploying the BD FACSLyric™ with HighRes automation can schedule a consultation today. More information can be found at highres.com.

About HighRes

HighRes partners with life science organizations to implement intelligent data and lab automation workflows that empower every team member to plan and execute efficient and reproducible science. Visit our new website to learn more at highres.com.

HighRes Media Contact

Thomas Rawlins
trawlins@highres.com

1 RUO disclaimer for US: BD FACSLyric™ Flow Cytometers are Class 1 Laser Products. The BD FACSLyric™ Flow Cytometer is For Research Use Only. Not for use in diagnostic or therapeutic procedures.

 

Blog

Read more about how we’re connecting science, technology, and the humans behind discovery.

HighRes Blog

Subscribe to the HighRes Blog

Get the latest insights weekly delivered right to your inbox.